Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CeraLyte 90 in Burn Patients
NCT02124265Phase 1Terminated
- Sponsor
- Johns Hopkins University
- Start
- May 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of CeraLyte in Thermal Burn, sponsored by Johns Hopkins University. Primary endpoint: Number of Participants With a 20% Decrease in Required IV Fluid at 24 hours. Started May 2013; status: terminated.
02
Drugs
CeraLyte
03
Conditions
Thermal Burn
Beyond the preview
Go deeper on NCT02124265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02124265.